To Evaluate the Efficacy and Safety of HUC3-053 in Patients With Dry Eye Syndrome

NCT06388070 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

297

Enrollment

INDUSTRY

Sponsor class

Conditions

Dry Eye Syndromes

Interventions

DRUG: HA 0.3%
DRUG: Hyalein Mini Eye Drops

Sponsor

Huons Co., Ltd.